SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
428CuraGen Appoints Dr. Frank M. Armstrong as Chief Executive Officer Thursday Marcnigel bates-3/30/2006
427CuraGen and TopoTarget Announce Initiation of First NCI-sponsored Clinical Trialnigel bates-3/29/2006
426CuraGen and TopoTarget Initiate Phase Ib/II Clinical Trial with PXD101 and Velcanigel bates-3/22/2006
425[Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimtuck-3/3/2006
424CuraGen Announces Phase II Results on Velafermin for the Prevention of Oral Muconigel bates-2/21/2006
423[CR011, a Fully Human Monoclonal Antibody-Auristatin E Conjugate, for the Treatmtuck-2/17/2006
422[Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patituck-2/16/2006
421Increasing competition for 454 from Solexa - Message 22149822nigel bates-2/9/2006
420Too bad this board is so quiet! In and holding CRGN.lindalib-2/9/2006
419Curagen Up; Piper Upgrades On Multiple Myeloma Drug By JOSEE ROSE February 6, 20Jim Oravetz-2/6/2006
418PXD101 goes to PII for T-Cell Lymphomas BRANFORD, Conn., Feb. 1 /PRNewswire-Firtuck-2/1/2006
417NCBI Adopts Standard for Accepting 454 Life Sciences' Sequencing Data Fridaynigel bates-1/27/2006
416Keygene Selects 454 Life Sciences' Novel Sequencing Technology to Enable Larnigel bates-1/12/2006
415>>BRANFORD, Conn., Jan. 11 /PRNewswire-FirstCall/ -- 454 Life Sciences Cortuck-1/11/2006
414CuraGen and Bayer Update Agreement for the Development of BAY 76-7171 (Formerly nigel bates-12/20/2005
413454 Life Sciences Initiates Collaborative Research Agreement with the Broad Instnigel bates-12/19/2005
412<i>I have no position</i> Premarket firesale on today's news...nigel bates-12/13/2005
411CuraGen Announces Preliminary Top-line Phase II Results on Velafermin Tuesday Denigel bates-12/13/2005
410PXD101 PI preliminary results: >>BRANFORD, Conn., Dec. 12 /PRNewswire-Firtuck-12/12/2005
409454 Life Sciences and the Genome Sequencing Center at Washington University Schonigel bates-12/7/2005
408Look out Hollis-Eden. FGF-20 found to be radioprotective: >>Int J Radiattuck-11/23/2005
407[PXD101 Phase I results] >>BRANFORD, Conn., Nov. 18 /PRNewswire-FirstCalltuck-11/18/2005
406[CR002 for kidney inflammation; Phase I results presented] >>BRANFORD, Cotuck-11/14/2005
405Innovation Awards A Better Idea By MICHAEL TOTTY Staff Reporter of THE WALL STRJim Oravetz-10/24/2005
404New DNA sequencer to ‘democratize’ research field Abram Katz , New Haven RegisJim Oravetz-10/14/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News